Gastrointestinal (GIST)

Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors

ClinicalTrials.gov ID NCT06948955

Sponsor Cogent Biosciences, Inc.

Information provided by Cogent Biosciences, Inc. (Responsible Party)

Trial Information: https://clinicaltrials.gov/study/NCT06948955


Call to learn more: 253-220-5003


Erica Stupfel

e*design Creative Services specializes in making professional design available to small companies and individuals. I understand the importance in brand identity and how a positive visual representation of your product or service can make the difference between success and failure. Your ideas and vision combined with my marketing and design expertise will be a sure success story.

https://www.edesigncreative.com
Next
Next

Breast Cancer